Remdesivir has been launched under the brand name Remdac in the Indian market. Meant to treat patients suffering from severe symptoms of COVID-19, it will be priced at Rs 2,800 per 100 mg vial.
Remdac is the most economical Remdesivir brand in India, the manufacturing company Zydus Cadila was quoted as saying by Hindustan Times (HT).
The company said the drug will be made available across India through the group’s strong distribution chain reaching out to government and private hospitals treating COVID-19 patients.
“Remdac is the most affordable drug as we would like to enable patients to have access to this critical drug in the treatment of Covid-19,” Cadila Healthcare Managing Director Dr. Sharvil Patel was quoted as saying by HT.
New Delhi: Delhi Metro Rail Corporation (DMRC) claimed to have scaled the highest point till… Read More
Bhubaneswar: The Odisha Vigilance sleuths on Sunday apprehended Assistant Agriculture Officer lock Technology Manager and… Read More
New Delhi: In a revealing account, Elon Musk has shed light on the dramatic circumstances… Read More
Kolkata: With emotions running high well before Indian and Pakistan clash for Champions Trophy in… Read More
Bhubaneswar: The India Meteorological Department (IMD) has issued nowcast warning for six districts of Odisha… Read More
Bhubaneswar: Excitement is reaching fever pitch as millions of fans from India and Pakistan tune… Read More
This website uses cookies.
